ACAD - ACADIA Pharmaceuticals Stock Trading

ACADIA Pharmaceuticals Inc.(NASDAQ: ACAD) stock trading, description, contact, officers and directors.

About ACADIA Pharmaceuticals Inc.

None

Stock Information

ACADIA Pharmaceuticals Inc. Company Name:

ACAD Stock Symbol:

NASDAQ Market:

Get ACAD Alerts

News, Short Squeeze, Breakout and More Instantly...

ACAD - The New England Journal of Medicine Publishes Results from the Phase 3 HARMONY Study Evaluating Pimavanserin in Patients with Dementia-Related Psychosis

- Pimavanserin met the primary endpoint of reduced risk of relapse of psychosis by 2.8 fold compared to placebo - Pimavanserin met the secondary endpoint of significantly reducing trial discontinuation for any reason by 2.2 fold Acadia Pharmaceuticals Inc. (Nasda...
ACAD - Acadia Pharmaceuticals to Announce Second Quarter 2021 Financial Results on August 4, 2021

Company to host conference call and webcast on Wednesday, August 4, 2021, at 4:30 p.m. Eastern Time Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report second quarter 2021 financial results on Wednesday, August 4, 2021, after the close of the U.S. ...
ACAD - Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the Alzheimer's Association International Conference 2021 (AAIC)

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that three scientific presentations in dementia-related psychosis (DRP) will be shared at the Alzheimer’s Association International Conference ® 2021 (AAIC ® ), being held July 26-30, 2021 in Denver, Col...